Navigation Links
Repligen Licenses Patent Rights for Treatment of Bipolar Disorder
Date:3/31/2009

WALTHAM, Mass., March 31 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) announced today that it has exclusively licensed worldwide rights for the use of uridine in the treatment of patients with bipolar disorder from McLean Hospital. The use of uridine in the treatment of patients with bipolar disorder is currently the subject of a patent application and upon issue, the patent will remain in force until 2025 prior to any regulatory extensions. Under the terms of the license agreement, McLean will receive an upfront payment, development milestones and royalties upon successful commercialization of uridine for bipolar disorder. McLean Hospital is the largest psychiatric facility of Harvard Medical School and maintains the largest research program of any private, U.S. psychiatric hospital. Repligen is developing RG2417, an oral formulation of uridine, as a treatment for the depressive symptoms of bipolar disorder based on positive results of a previously reported Phase 2a clinical trial.

"Bipolar disorder affects more than two million adults in the United States," stated Walter C. Herlihy, President and Chief Executive Officer of Repligen Corporation. "Treatment of the symptoms of bipolar depression remains an area of significant unmet medical need, as current therapies are ineffective and result in numerous side effects. We look forward to completion of our ongoing proof-of-concept clinical trial which could provide a new approach to the treatment of bipolar depression."

Repligen is currently conducting a Phase 2b clinical trial of RG2417 designed to confirm and extend the positive results obtained in a Phase 2a clinical trial which demonstrated that RG2417 was well tolerated and resulted in a statistically significant improvement in the symptoms of bipolar depression over the six-week treatment period
'/>"/>

SOURCE Repligen Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Repligen Announces ISO 9001:2000 Certification
2. Repligen Reports Second Quarter Fiscal Year 2009 Financial Results
3. Repligen Initiates Phase 2b Clinical Trial of RG2417 in Bipolar Disorder
4. Repligen Announces Conference Call of Second Quarter Fiscal Year 2009 Results Thursday, November 6th, 10:00 a.m. EST
5. Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors
6. Repligen Announces Share Repurchase Program
7. Repligen Announces Conference Call to Update Orencia(R) Lawsuit
8. Repligen Elects Earl Henry, M.D. to the Board of Directors
9. Repligen to Present at Upcoming Healthcare Conferences Wednesday, November 28th and Wednesday, December 5th
10. Repligen Reports Second Quarter Fiscal Year 2008 Financial Results
11. Recovery Audit Contractor HealthDataInsights Licenses Milliman Care Guidelines(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... The presence of chronic inflammation in benign ... prostate cancer, and this association was found even ... according to a study published in Cancer ... the American Association for Cancer Research. , An ... participants of the placebo arm of the Prostate ...
(Date:4/17/2014)... pain relief targets that could be used to ... King,s College London made the discovery when researching ... of the body. , Dr Marzia Malcangio said: ... pain generation and our findings could help chemotherapy ... One potential side effect of some chemotherapy drugs ...
(Date:4/17/2014)... Biology and Medicine a multidisciplinary research team ... in the Institute of Genomic Biology (IGB) on ... describe their recent work on subcellular redox homeostasis. ... functions including energy metabolism, signaling, and transcriptional processes. ... cellular behavior, redox status has been recognized as ...
(Date:4/17/2014)... a review published in the April issue of ... Feinstein Institute for Medical Research, says it,s time to ... approach to treating sepsis, which kills millions worldwide ... occurs when molecules released into the bloodstream to fight ... Inflammation is necessary for maintaining good health without ...
(Date:4/17/2014)... 17, 2014U.S. military personnel who served in Iraq ... traumatic brain injury (TBI) were compared to military ... medical reasons. Differences in measures of overall disability, ... after injury are reported in an article in ... from Mary Ann Liebert, Inc., publishers. The article ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:New pain relief targets discovered 2Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2
... Patient undergoing multiple tests to diagnose and investigate ... which seemed to be promoted //by advanced imaging ... (ESC) has recommended that an inter-disciplinary collaboration of ... non-invasive diagnosis could ensure effective diagnosis of heart ...
... of Medical Research (MIMR) have developed a new machine, ... babies constantly. ,Although it was the ... monitor continuously, the fluctuating BP and brain oxygen levels ... the Monash Institute of Medical Research (MIMR) are carrying ...
... University of Bristol have recommended that knee cartilage injuries ... any signs of osteoarthritis progression. ,'The ... only about 12 months and this is the first ... ,The study, 'Maturation of tissue engineered cartilage implanted ...
... Santosh Baniya whose parents were diagnosed with HIV was ... the disease//. ,Santosh Baniya succumbed to his ... Ahmedabad last week. ,The boy’s parents, both ... ago. Investigations have suggested that Santosh Baniya feared surviving ...
... conducted by Stephanie Chiuve it was found that a healthy ... ,U.S. researchers stated that patients suffering from blood pressure and ... ,It was discussed that middle aged men can reduce their ... and change their drinking and smoking habits. ,But ...
... New Zealand Winegrowers are affected by the type 3 virus ... of grapevines//. ,But most of the winegrowers have ... are free from the virus. New Zealand Winegrowers science and ... is being done to understand the virus spread and ongoing ...
Cached Medicine News:Health News:Collaborative use of Imaging Techniques proved effective in Cardiovascular Diagnosis – ESC Recommend 2Health News:Collaborative use of Imaging Techniques proved effective in Cardiovascular Diagnosis – ESC Recommend 3Health News:Preterm Babies Benefited from a New NI Spectroscopy 2Health News:Engineered Tissue Implants benefited Knee Injured patients 2
(Date:1/15/2014)... BreedIT Corp (OTC: BRDT), through its Israeli ... sophisticated agro-breeding solutions for plant breeders and researchers, today ... of directors appointed chemistry and pharmaceutical industry expert Dr. ... the board. From 1975 to 2012, Dr. ...
(Date:1/15/2014)... Tegra Medical is very pleased to announce the appointment of ... Executive Officer.  Mark was promoted from his current role of ... four facilities in Massachusetts , ... Medical in 2012 with 20+ years of broad-based operations, sales, ...
(Date:1/15/2014)... , Jan. 15, 2014 The Cadence Fitness ... Fitness Center by the Medical Fitness Association, a non-profit ... achieve their full potential. The Cadence Fitness & Health ... western suburbs and second in the Chicagoland area. ...
Breaking Medicine Technology:BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
... VIEW, Calif., Nov. 11 MAP Pharmaceuticals, Inc. (Nasdaq: ... the Lazard Capital Markets 6th Annual Healthcare Conference on Wednesday, ... City. , A live webcast of the presentation will ... website at http://www.mappharma.com . A replay will also be ...
... Nov. 10 Inc. magazine has ranked West Physics ... of the fastest-growing private companies in the U.S. West Physics ... 100 Health Companies and No. 32 on the list of the ... Consulting posted three-year revenue growth of 327.8% to make the list. ...
Cached Medicine Technology:West Physics Consulting Makes the 2009 Inc. 5000 List 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: